Bio Essence Corp (BIOE) stock
BIOEOTCPharmaceutical PreparationsFiscal year ends December 31
$0.42+0.03 (+7.72%)
Close on Oct 19, 2026Market cap $22.70MP/E 10.5Yield –
Bio Essence free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Bio Essence's free cash flow for the twelve months ending Dec 31, 2023 was -$1.03M. For fiscal 2023 it was -$1.03M.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | -$1.03M | – |
| FY2022 | Dec 31, 2022 | -$706.98K | – |
| FY2021 | Dec 31, 2021 | -$1.41M | – |
| FY2020 | Dec 31, 2020 | -$740.11K | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2023 | Dec 31, 2023 | -$204.09K | – |
| Q4 FY2022 | Dec 31, 2022 | -$79.43K | – |
| Q4 FY2021 | Dec 31, 2021 | -$232.41K | – |
| Q3 FY2021 | Sep 30, 2021 | -$182.14K | – |
| Q2 FY2021 | Jun 30, 2021 | -$830.88K | – |
| Q1 FY2021 | Mar 31, 2021 | -$168.18K | – |
| Q4 FY2020 | Dec 31, 2020 | -$242.47K | – |
See a number that looks wrong?